Unit 150
2248 Elgin Avenue
Port Coquitlam, BC V3C 2B2
Canada
https://www.myndsciences.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Lyle Oberg M.D. | Co-Founder & Executive Chairman of the Board | N/A | N/A | 1960 |
Mr. John Campbell | President,CEO & Director | N/A | N/A | 1972 |
Dr. Wilfred A. Jefferies | Co-Founder & Chief Science Officer | N/A | N/A | 1958 |
Mr. Lih-Ming Tam | CFO & Senior Controller | N/A | N/A | N/A |
Dr. Chaahat S.B Singh | Senior Operations & Research Manager | N/A | N/A | N/A |
Mr. Luke Warkentin | Vice President of Corporate Development | N/A | N/A | N/A |
Dr. Iryna Saranchova Ph.D. | Chief Clinical Officer | N/A | N/A | N/A |
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
MYND Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.